RT Journal Article SR Electronic T1 Telmisartan and ramipril were equivalent, but their combination increased adverse events in vascular disease or diabetes JF Evidence Based Medicine JO Evid Based Med FD BMJ Publishing Group Ltd SP 147 OP 147 DO 10.1136/ebm.13.5.147 VO 13 IS 5 YR 2008 UL http://ebm.bmj.com/content/13/5/147.abstract AB